North America extentended its dominance for digitalization hiring among clinical trial operations industry companies in the three months ending October.
The number of roles in North America made up 50.4 per cent of total digitalization jobs – up from 42.7 per cent in the same quarter last year.
That was followed by Asia-Pacific, which saw a minus three year-on-year percentage point change in digitalization roles.
The figures are compiled by GlobalData, who track the number of new job postings from key companies in various sectors over time. Using textual analysis, these job advertisements are then classified thematically.
GlobalData's thematic approach to sector activity seeks to group key company information by topic to see which companies are best placed to weather the disruptions coming to their industries.
These key themes, which include digitalization, are chosen to cover "any issue that keeps a CEO awake at night".
By tracking them across job advertisements it allows us to see which companies are leading the way on specific issues and which are dragging their heels - and importantly where the market is expanding and contracting.
Which countries are seeing the most growth for digitalization roles in the clinical trial operations industry?
The fastest growing country was the United States, which saw 42.7 per cent of all digitalization job adverts in the three months ending July last year, increasing to 50.4 per cent in the three months ending October this year.
That was followed by France (up 0.1 percentage points), Poland (up -0.7), and Germany (up -0.8).
The top country for digitalization roles in the clinical trial operations industry is the United States which saw 50.4 per cent of all roles in the three months ending October.
Which cities are the biggest hubs for digitalization workers in the clinical trial operations industry?
Some 2.6 per cent of all clinical trial operations industry digitalization roles were advertised in Shanghai (China) in the three months ending October - more than any other city.
That was followed by Cambridge (United States) with 2.6 per cent, Cambridge (United Kingdom) with 1.2 per cent, and Boston (United States) with 1.1 per cent.